Vitamin D Sleep Quality Randomized Trial: What the Evidence Says

Vitamin D Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass ar

3 min read · 571 wordsReviewed June 2026
Glass container with amber capsules spilling out on a white background. - Evidence evidence guide for vitamin D sleep quality randomized trial
Photo by Jonathan Borba on Pexels · Pexels License

Quick Answer

Vitamin D Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 systematic review, 1 randomized trial.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Vitamin D Sleep Quality Randomized Trial: What the Evidence Says

Quick Answer

Vitamin D Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 systematic review, 1 randomized trial.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis. systematic review 1 2026-05-20 10.3389/fneur.2026.1790771
Effects of peppermint ( Mentha x piperita L.) oil on cardiometabolic outcomes in patients with pre- and stage 1 hypertension: A placebo randomized controlled trial randomized trial 2 2026-04-23 10.1371/journal.pone.0344538

What The Sources Report

  • However, the evidence base for TCM pharmacologic interventions in hemodialysis-related RLS remains unclear. [Zhang J (2026); evidence level 1]
  • Pharmacologic therapy significantly improved IRLS scores (MD -7.84), sleep quality (SMD -0.82), and quality of life (SMD 0.48). [Zhang J (2026); evidence level 1]
  • Globally, hypertension is renowned as the leading risk factor for cardiovascular disease morbidity and mortality. [Sinclair Jonathan (2026); evidence level 2]
  • High blood pressure ranks first among modifiable risk factors attributable to cardiovascular disease aetiology, accounting for the largest proportion of coronary heart disease, heart failure, and stroke events. [Sinclair Jonathan (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For vitamin D sleep quality randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Zhang J (2026). Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis.. DOI: 10.3389/fneur.2026.1790771. PMCID: PMC13230204. PMID: 42246040. https://pmc.ncbi.nlm.nih.gov/articles/PMC13230204/
  • Sinclair Jonathan (2026). Effects of peppermint ( Mentha x piperita L.) oil on cardiometabolic outcomes in patients with pre- and stage 1 hypertension: A placebo randomized controlled trial. DOI: 10.1371/journal.pone.0344538. PMCID: PMC13105356. PMID: 42024666. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13105356/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed June 25, 2026 by Migaku Evidence Review

Related content

← All GuidesSupplement Reference →